Author:
Gantert Markus,Lewrick Felicitas,Adrian Joanna E.,Rössler Jochen,Steenpaß Thomas,Schubert Rolf,Peschka-Süss Regine
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference37 articles.
1. J. M. Metselaar, E. Mastrobattista, and G. Storm. Liposomes for intravenous drug targeting: design and applications. Mini Rev. Med. Chem. 2:319–329 (2002) doi: 10.2174/1389557023405873 .
2. R. J. Debs, T. D. Heath, and D. Papahadjopoulos. Targeting of anti-Thy 1.1 monoclonal antibody conjugated liposomes in Thy 1.1 mice after intravenous administration. Biochim. Biophys. Acta. 901:183–190 (1987) doi: 10.1016/0005-2736(87)90114-3 .
3. I. Ahmad, M. Longenecker, J. Samuel, and T. M. Allen. Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res. 53:1484–1488 (1993).
4. Y. L. Tseng, R. L. Hong, M. H. Tao, and F. H. Chang. Sterically stabilized anti-idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B-cell lymphoma model. Int. J. Cancer. 80:723–730 (1999) doi: 10.1002/(SICI)1097-0215(19990301)80:5<723::AID-IJC16>3.0.CO;2-L .
5. J. W. Park, K. Hong, D. B. Kirpotin, G. Colbern, R. Shalaby, J. Baselga, Y. Shao, U. B. Nielsen, J. D. Marks, D. Moore, D. Papahadjopoulos, and C. C. Benz. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin. Cancer Res. 8:1172–1181 (2002).
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献